Emergent Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.08M Buy
4,078
+439
+12% +$116K 0.56% 37
2026
Q2
$923K Buy
3,639
+201
+6% +$46.8K 0.48% 39
2026
Q1
$840K Buy
3,438
+130
+4% +$30.3K 0.5% 35
2025
Q4
$685K Buy
3,308
+322
+11% +$63.7K 0.39% 58
2025
Q3
$554K Buy
2,986
+11
+0.4% +$1.89K 0.32% 60
2025
Q2
$454K Buy
2,975
+42
+1% +$6.46K 0.29% 69
2025
Q1
$486K Sell
2,933
-881
-23% -$138K 0.35% 55
2024
Q4
$552K Buy
3,814
+300
+9% +$46.5K 0.4% 49
2024
Q3
$569K Buy
3,514
+564
+19% +$89.9K 0.42% 45
2024
Q2
$433K Buy
2,950
+970
+49% +$144K 0.35% 57
2024
Q1
$313K Buy
1,980
+38
+2% +$6.05K 0.27% 67
2023
Q4
$304K Buy
+1,942
New +$298K 0.28% 72

Other funds holding JNJ

Emergent Wealth Advisors's JNJ Position: Q3 2026 in Review

Emergent Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 12% in Q3 2026, buying an estimated $116K and bringing the position to 4,078 shares worth $1.08M. The position accounts for 0.56% of the portfolio, ranked #37.

Emergent Wealth Advisors first reported a position in JNJ in Q4 2023 and has held it in 12 quarters since. 267 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Emergent Wealth Advisors held 4,078 shares of Johnson & Johnson worth $1.08M as of Q3 2026.
  • Emergent Wealth Advisors bought 439 Johnson & Johnson shares in Q3 2026, an estimated $116K.
  • Johnson & Johnson made up 0.56% of Emergent Wealth Advisors's portfolio in Q3 2026, its #37 holding.
  • Emergent Wealth Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 12 quarters since.
  • 267 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Emergent Wealth Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.